BCAL Diagnostics

BCAL Diagnostics Net Debt/FCF

The Net Debt to Free Cash Flow Ratio of BCAL Diagnostics (BDX.AX) as of Oct 17, 2026 is 0.31. In the previous year, Net Debt to Free Cash Flow Ratio was 0.87 — a change of -64.50% (lower).

Net Debt/FCF

0.31

YoY

-64.50%

Last updated:

Net Debt to Free Cash Flow Ratio of BCAL Diagnostics is 2025 0.31 . Net Debt to Free Cash Flow Ratio of BCAL Diagnostics was 2024 0.87 . It decreases by -64.50% lower compared to the previous year.

The BCAL Diagnostics Net Debt/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/FCF
Date
Net Debt/FCF
Jan 1, 2018
-0.39 AUD
Jan 1, 2019
0.52 AUD
Jan 1, 2020
0.17 AUD
Jan 1, 2021
2.82 AUD
Jan 1, 2022
2.95 AUD
Jan 1, 2023
0.33 AUD
Jan 1, 2024
0.87 AUD
Jan 1, 2025
0.31 AUD
The BCAL Diagnostics Net Debt/FCF history
YEARNet Debt/FCFYoY
0.31-64.50%
0.87+164.66%
0.33-88.83%
2.95+4.76%
2.82+1,512.49%
0.17-66.39%
0.52-231.91%
-0.39—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

BCAL Diagnostics Stock analysis

What does BCAL Diagnostics do? BCAL Diagnostics Ltd, based in Sydney, Australia, operates in the Health Care sector within the Biotechnology industry. The company develops innovative blood screening tests for early breast cancer detection, focusing on a lipid biomarker-based approach known as the BCAL test. This technology complements existing imaging methods like mammograms and aims to support screening and monitoring for women of all ages and backgrounds. BCAL Diagnostics has partnered with Precion Inc. to advance clinical trials and regulatory approvals for its diagnostic solutions. BCAL Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BCAL Diagnostics stock

Net Debt to Free Cash Flow Ratio of BCAL Diagnostics is 0.31 in 2025.

Net Debt to Free Cash Flow Ratio of BCAL Diagnostics changed from 0.87 to 0.31, representing a -64.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio BCAL Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's BCAL Diagnostics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — BCAL Diagnostics

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — BCAL Diagnostics